JP2009517368A5 - - Google Patents

Download PDF

Info

Publication number
JP2009517368A5
JP2009517368A5 JP2008541751A JP2008541751A JP2009517368A5 JP 2009517368 A5 JP2009517368 A5 JP 2009517368A5 JP 2008541751 A JP2008541751 A JP 2008541751A JP 2008541751 A JP2008541751 A JP 2008541751A JP 2009517368 A5 JP2009517368 A5 JP 2009517368A5
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
group
ethyl
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008541751A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009517368A (ja
JP5374157B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/068867 external-priority patent/WO2007060215A2/en
Publication of JP2009517368A publication Critical patent/JP2009517368A/ja
Publication of JP2009517368A5 publication Critical patent/JP2009517368A5/ja
Application granted granted Critical
Publication of JP5374157B2 publication Critical patent/JP5374157B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008541751A 2005-11-24 2006-11-24 (r)−アリールアルキルアミノ誘導体類と、それらを含有する薬剤組成物 Active JP5374157B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05111257.1 2005-11-24
EP05111257 2005-11-24
PCT/EP2006/068867 WO2007060215A2 (en) 2005-11-24 2006-11-24 (r)-arylkylamino derivatives and pharmaceutical compositions containing them

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013043160A Division JP5730343B2 (ja) 2005-11-24 2013-03-05 (r)−アリールアルキルアミノ誘導体類と、それらを含有する薬剤組成物

Publications (3)

Publication Number Publication Date
JP2009517368A JP2009517368A (ja) 2009-04-30
JP2009517368A5 true JP2009517368A5 (enExample) 2009-12-24
JP5374157B2 JP5374157B2 (ja) 2013-12-25

Family

ID=37865701

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008541751A Active JP5374157B2 (ja) 2005-11-24 2006-11-24 (r)−アリールアルキルアミノ誘導体類と、それらを含有する薬剤組成物
JP2013043160A Active JP5730343B2 (ja) 2005-11-24 2013-03-05 (r)−アリールアルキルアミノ誘導体類と、それらを含有する薬剤組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013043160A Active JP5730343B2 (ja) 2005-11-24 2013-03-05 (r)−アリールアルキルアミノ誘導体類と、それらを含有する薬剤組成物

Country Status (18)

Country Link
US (1) US8026367B2 (enExample)
EP (1) EP1951663B1 (enExample)
JP (2) JP5374157B2 (enExample)
CN (1) CN101360706B (enExample)
AU (1) AU2006316452B2 (enExample)
CA (1) CA2629935C (enExample)
CY (1) CY1118109T1 (enExample)
DK (1) DK1951663T3 (enExample)
ES (1) ES2597843T3 (enExample)
HR (1) HRP20161260T1 (enExample)
HU (1) HUE031466T2 (enExample)
LT (1) LT1951663T (enExample)
PL (1) PL1951663T3 (enExample)
PT (1) PT1951663T (enExample)
RS (1) RS55192B1 (enExample)
RU (1) RU2458051C2 (enExample)
SI (1) SI1951663T1 (enExample)
WO (1) WO2007060215A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8793748B2 (en) * 2007-07-26 2014-07-29 The Directv Group, Inc. Method and system for controlling communication between a user device and a content delivery network
US20090028317A1 (en) * 2007-07-26 2009-01-29 The Directv Group, Inc. Method and system for providing callbacks from a user device using an ip network
AU2008313669B2 (en) * 2007-10-18 2014-01-16 Dompe' Farmaceutici S.P.A. (R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
EP2166006A1 (en) * 2008-09-18 2010-03-24 Dompe' S.P.A. 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
MA32975B1 (fr) 2008-12-22 2012-01-02 Chemocentryx Inc Antagonistes de c5ar
SI2585064T1 (sl) 2010-06-24 2017-08-31 Chemocentryx, Inc. Antagonisti C5AR
TW201329025A (zh) 2011-11-01 2013-07-16 Astex Therapeutics Ltd 醫藥化合物
CN113121415B (zh) 2014-09-29 2025-09-02 凯莫森特里克斯股份有限公司 制备C5aR拮抗剂的方法和中间体
CN104623687B (zh) * 2015-03-11 2017-09-05 中国科学院上海高等研究院 利用美登醇制备的抗体药物偶联物及其制备方法和应用
CN108601790A (zh) 2016-01-14 2018-09-28 凯莫森特里克斯股份有限公司 C3肾小球病的治疗方法
EP3498269A1 (en) * 2017-12-12 2019-06-19 Dompé farmaceutici S.p.A. C5ar inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain
TW202012396A (zh) * 2018-04-18 2020-04-01 美商德洛斯股份有限公司 具乙烯磺醯胺部分之k-ras調節劑
EP4059497A1 (en) 2021-03-17 2022-09-21 Dompé farmaceutici S.p.a. C5ar1 inhibitors for treating hypersensitivity reactions to taxanes
WO2022195017A1 (en) 2021-03-17 2022-09-22 Dompe' Farmaceutici Spa C5ar1 inhibitors for treating hypersensitivity reactions to taxanes
EP4397306A1 (en) 2023-01-05 2024-07-10 Dompe' Farmaceutici S.P.A. C5ar1 inhibitors for use in the treatment of ocular mucous membrane pemphigoid and/or oral mucous membrane pemphigoid

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62252755A (ja) * 1986-04-11 1987-11-04 Daikin Ind Ltd 新規n−ベンジルベンズアミド誘導体およびこれを有効成分として含有する除草剤
US4861891A (en) * 1988-08-31 1989-08-29 Pfizer Inc. Antidepressant N-substituted nicotinamide compounds
JPH09301933A (ja) * 1996-05-14 1997-11-25 Sumika Fine Chem Kk アミン類の製造方法
US6020335A (en) * 1997-02-06 2000-02-01 Pfizer Inc (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
EP1029851B1 (en) * 1997-10-14 2005-04-20 Mitsubishi Pharma Corporation Piperazine compounds and medicinal use thereof
PT1031569E (pt) * 1997-10-27 2010-05-10 Toyama Chemical Co Ltd Sal de um derivado do ácido 7-isoindolino-quinolonocarboxílico, o seu mono-hidrato e composição que o contém como ingrediente activo
AU1631799A (en) * 1997-12-15 1999-07-05 Board Of Trustees Of The University Of Arkansas, The Fungicidal amides
IT1303249B1 (it) 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
US6498165B1 (en) * 1999-06-30 2002-12-24 Merck & Co., Inc. Src kinase inhibitor compounds
US20040058903A1 (en) * 2000-10-05 2004-03-25 Hisashi Takasugi Benzamide compounds as apo b secretion inhibitors
ITMI20010395A1 (it) 2001-02-27 2002-08-27 Dompe Spa Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
PT1818325E (pt) * 2001-04-16 2010-05-12 Schering Corp Ciclobuteno-1,2-dionas 3,4-di-substituídas como ligandos de receptor de quimoquina cxc
EP1434775A1 (en) * 2001-10-12 2004-07-07 Schering Corporation 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
AU2003900587A0 (en) * 2003-02-11 2003-02-27 Fujisawa Pharmaceutical Co., Ltd. Hdac inhibitor
US20050222408A1 (en) * 2003-07-14 2005-10-06 University Of Tennessee Research Foundation Heterocyclic amides with anti-tuberculosis activity
NZ545747A (en) * 2003-08-06 2010-06-25 Senomyx Inc T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
US7671212B2 (en) * 2003-12-22 2010-03-02 Schering Corporation Isothiazole dioxides as CXC- and CC-chemokine receptor ligands
GT200500013A (es) * 2004-01-23 2005-08-10 Amidas herbicidas
ATE444286T1 (de) * 2004-03-23 2009-10-15 Dompe Pha R Ma Spa Res & Mfg 2-phenylpropionsäurederivate und diese enthaltende pharmazeutische zusammensetzung

Similar Documents

Publication Publication Date Title
JP2009517368A5 (enExample)
JP2013506637A5 (enExample)
JP5085659B2 (ja) L−cpt1阻害剤として有用なインダゾール誘導体
JP5708936B2 (ja) 置換アミド化合物
RU2008125433A (ru) (r)-арилалкиламинопроизводные и содержащие их фармацевтические композиции
JP2010501587A5 (enExample)
TW200524575A (en) Biaryl linked hydroxamates: preparation and pharmaceutical applications
RU2007128949A (ru) Конденсированные бициклические карбоксамидные производные, используемые в качестве ингибиторов схсr2 для лечения воспалений
JP2004509953A5 (enExample)
CA2396824A1 (en) Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
JP2006519258A5 (enExample)
CZ299237B6 (cs) 2-(Iminomethyl)aminofenylové deriváty, jejich príprava, jejich použití jako léciva a farmaceutické kompozice, které je obsahují
BR112012007411B1 (pt) Composto, processo para sua preparação e composição farmacêutica contendo o mesmo
RU2014121394A (ru) Двузамещенные соединения диамино-3,4-циклобутен-3-диона-1,2, приемлемые для лечения паталогий, опосредованных хемокинами
AU2002342859A1 (en) Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPS)
EP1470102A1 (en) Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
AU2003239296A1 (en) Substituted methylene amide derivatives as Modulators of Protein Tyrosine Phosphatases (PTPs)
US20040198780A1 (en) Inhibitors of cathepsin S
JPWO2005026127A1 (ja) プラスミノゲンアクチベータインヒビター−1阻害剤
JP2013509376A5 (enExample)
JP2005514432A5 (enExample)
JP4939226B2 (ja) チアゾール環を含むカルボン酸誘導体およびその医薬用途
RU2020122678A (ru) ИНГИБИТОРЫ C5aR ДЛЯ ПРИМЕНЕНИЯ ДЛЯ ЛЕЧЕНИЯ ИНДУЦИРОВАННОЙ ХИМИОТЕРАПИЕЙ ЯТРОГЕННОЙ БОЛИ
WO2012038904A1 (fr) Derives de nicotinamide, leur preparation et leur application en therapeutique
JP2021505647A5 (enExample)